HOME

CONTACT

SITE MAP

 

SUPPORTED BY 

Biomarin

  



BH4 Screening Tests
General information
Pterins (neopterin, biopterin) in urine (essential)
Dihydropteridine reductase (DHPR) activity in RBC on Guthrie card (essential)
Loading test with BH4 (recommended)
Neurotransmitter metabolites (5HIAA, HVA, etc.) and pterins in CSF
Folates (5MTHF) in CSF
Enzyme activity - PTPS
Enzyme activity
GTPCH | PCD | DHPR | SR
in RBC, WBC or FB
Phenylalanine loading test in patients with DRD (Segawa disease)
DNA analysis

 

 
Databases Deficiency Pterins Conferences Literature Zurich
GTPCH
GFRP
PTPS
SR
PCD
DHPR
BH4 Deficiencies - Screening Tests

Pterins (neopterin, biopterin and primapterin) in urine


Analysis of pterins

Liquid urinary samples or, even better, a random urine specimen dried on filter paper can be used1. Reduced urinary pterins are extremely unstable and are affected by daylight, temperature, and storage time. The recovery of urinary pterins in dried filter paper and stored at room temperature for one and two weeks showed good correlation with standard methods. A significant advantage of this method is that the samples can be mailed unfrozen in an envelope, speeding delivery and minimizing costs.

Typical urinary pterin profiles are as follows: in GTPCH deficiency neopterin and biopterin are very low; in PTPS deficiency neopterin and monapterin (isomer of neopterin) are very high and there are only traces of biopterin; in DHPR deficiency neopterin is normal or slightly increased and biopterin is very high; and in PCD deficiency neopterin is initially high, biopterin is in the subnormal range and primapterin (7-substituted biopterin) is present. Patients with the classical PKU excrete generally more neopterin and biopterin in urine than normal controls2.

By two-dimensional plotting of total biopterin versus percentage of biopterin, of the sum of neopterin plus biopterin, variants of HPA can be separated (Figure).

Collection of liquid urine specimens:

Pipette 5 ml of fresh random urine into a centrifugation vial and adjust pH to 1.0-1.5 with 6M HCl. Add 100 mg of manganese dioxide (MnO2, No. 5957, Merck, Darmstadt, Germany) and shake for 5 min at room temperature. Centrifuge for 10 min at 4000 rpm. Immediately transfer 1 ml of the clear supernatant into a vial for shipment. Wrap the vial in aluminum foil to protect from light.

Collection of dried urine specimens

Fresh random urine is processed as described for liquid specimen. Filter paper strips (3x5 cm, filter paper backing 165-0921, Bio-Rad, Richmond, USA) are dipped into the clear supernatant of the oxidized urine up to 1 cm below the upper edge. Excess urine is wiped off and the filter paper is left to completely dry at room temperature in dim light. The filter strip is then sent to the laboratory in an envelope by express mail.

Preconditions

The analysis of urinary pterins must be performed at elevated plasma phenylalanine levels (>400 umol/l) and not during treatment with a low-phenylalanine diet. Healthy newborns excrete relatively higher levels of pterins than children or adults3.

Handling

Native urine specimens should be stored in the dark at -20°C. Store oxidized samples in the dark at RT.

Pitfalls

Viral infections increase neopterin excretion in urine dramatically.



REFERENCES

  • Blau N, Kierat L, Heizmann CW, Endres W, Giudici T, Wang M. Screening for tetrahydrobiopterin deficiency in newborns using dried urine on filter paper. J. Inherit. Metab. Dis. 1992;15:402-404.
  • Blau N, Thöny B, Spada M, Ponzone A. Tetrahydrobiopterin and inherited hyperphenylalaninemias. Turk J Pediatr 1996;38:19-35.
  • Niederwieser A, Curtius HC, Gitzelmann R, Otten A, Baerlocher K, Blehova B, Berlow S, Grobe H, Rey F, Schaub J, Scheibenreiter S, Schmidt H, Viscontini M. Excretion of pterins in phenylketonuria and phenylketonuria variants. Helv. Paediatr. Acta. 1980;35:335-342.



 


Confidentiality of data relating to individual patients and visitors to the BH4 Web site, including their identity, is respected by this Web site. The Web site owners undertake to honour or exceed the legal requirements of medical/health information privacy that apply in the country and state where the Web site and mirror sites are located.

Web site and all contents © BH4.org 2005